Wu Chen currently serves as a Research Fellow in Medicine at Harvard Medical School and as a Health Science Specialist at Boston VA Research Institute, Inc., focusing on characterizing treatment responses for lung and bladder tumors through patient-derived tumor models. Prior experience includes roles as a Research Assistant at Auburn University, specializing in nanoparticle delivery systems for cancer therapy, and Deputy Manager of the Pharmaceutical Department at Tianji Health Medical Science and Technology co., LTD, where project management and data analysis were key responsibilities. Additional roles include chemistry scientist at WUXI APP Tec., where synthesis and purification of chemical molecules were conducted, and research assistant at the China State Institute of Pharmaceutical Industry, focusing on synthesis for osteoporosis treatment. Wu Chen holds a PhD in Pharmaceutics from Auburn University, a Master's degree in Medicinal Chemistry from the China State Institute of Pharmaceutical Industry, and a Bachelor's degree in Pharmacy from Shenyang Pharmaceutical University.
Boston VA Research Institute, Inc. (BVARI)
Founded in 1990, BVARI is one of Boston's only small non-profits in biomedical research. We are a strategic partner to the VA Boston Healthcare System, which maintains academic affiliations with several prestigious universities in Boston. We enable top-notch research programs, driving major advances in a number of high-priority disease areas affecting the US veteran population and translating to the general public. Our small business setting is ideal for highly intelligent and driven leaders wishing to make a big impact in the workplace. Every role at BVARI is essential to driving excellence, and every individual is highly valued and challenged to grow and thrive within our environment. We encourage shining stars who wish to push traditional corporate boundaries, deeply broaden their knowledge base, and influence outcomes to apply.